New investment in CVS Group plc

Summary by AI BETAClose X

Kelso Group Holdings Plc has invested in CVS Group plc, acquiring 130,000 shares at an average price of 1,387p, with CVS Group having a market capitalization of £971.0 million. Kelso highlights CVS Group's consistent long-term growth, with revenue increasing from £39 million to £673 million and EBITDA from £5.1 million to approximately £134 million since its 2007 IPO, alongside expansion to around 470 veterinary practices. Despite comparable companies trading at higher valuation multiples, CVS Group currently trades at approximately half the rating, with a P/E ratio of around 16x and an EV/EBITDA multiple of about 8.0x. Kelso believes CVS Group's strong balance sheet, with net debt of approximately £160 million as of December 31, 2025, and forecast EBITDA of around £140 million for the year ending June 30, 2026, presents a compelling investment opportunity, especially with the Competition and Markets Authority review nearing conclusion and potential FTSE 250 Index inclusion anticipated.

Disclaimer*

UK 100

Latest directors dealings